Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.
Financial Results:
Orchid Pharma Ltd reported Revenues for Q1FY24 of ₹182.92 Crores up from ₹130.99 Crore year on year, a rise of 39.64%.
Total Expenses for Q1FY24 of ₹174.04 Crores up from ₹148.01 Crores year on year, a rise of 17.59%.
Consolidated Net Profit of ₹9.40 Crores from -₹15.01 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.85, from -₹3.68 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.